The Randomized Controlled STRAWINSKI Trial: Procalcitonin-Guided Antibiotic Therapy after Stroke
Lena Ulm(The University of Queensland), Andreas Meisel(Humboldt-Universität zu Berlin), J. Wiemer(Thermo Fisher Scientific (Germany)), Sarah Hoffmann(Max Planck Institute for Molecular Biomedicine), Andreas Hartmann(Novartis (Switzerland)), Marcella Hermans(Vivantes Klinikum), Mira Katan(University Hospital of Basel), Sabine Hertel(Thermo Fisher Scientific (Germany)), Joan Montaner(Universitat Autònoma de Barcelona), Gerhard-Jan Jungehuelsing(Jüdisches Krankenhaus Berlin), Christian Meisel(University of Zurich), Ingo Schmehl(Unfallkrankenhaus Berlin), Christiane Dinter(Thermo Fisher Scientific (Germany)), Alejandro Bustamante(Hospital Universitari Germans Trias i Pujol), Frank A. Hamilton(National Institute of Diabetes and Digestive and Kidney Diseases), Darius G. Nabavi(Vivantes Klinikum), Stefan D. Anker(Bayer (Germany)), Bruno‐Marcel Mackert(Auguste-Viktoria-Klinik), Stefan Ebmeyer(University of Gothenburg)
Cited by 43
Related Papers
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2021|13.1k
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
|New England Journal of Medicine|2017|9.1k
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k
Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study
|The Lancet|1993|4.4k
Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes
|New England Journal of Medicine|2020|2.6k